Is Nonulcer Dyspepsia Improved by Treating Helicobacter pylori Infection?
Clinical research in nonulcer dyspepsia (NUD) is not straightforward. Reported studies show variation in the definition of NUD, the population groups studied, the endpoints assessed and symptoms evaluated. In attempting to give an overview of the benefit of treating Helicobacter pylori (HP) in this condition it is relevant first to consider these aspects.
KeywordsPlacebo Bismuth Erythromycin Gastritis Salicylate
Unable to display preview. Download preview PDF.
- 1.Working Party Report (1988) Management of dyspepsia. Lancet I:576–579Google Scholar
- 3.Lambert JR, Borromeo M, Korman MG, Hansky J (1987) Role of Campylobacter pyloridis in non-ulcer dyspepsia — a randomized controlled study. Gastroenterology 92 (5/2): 1488.Google Scholar
- 4.Borody T, Hennessy W, Daskalopoulos G, Carrick J, Hazell S (1987) Double blind trial of DeNol in nonulcer dyspepsia associated with Campylobacter pyloridis gastritis. Gastroenterology 92 (5/2): 1324.Google Scholar
- 6.Kang JY, Tay HH, Wee A, Guan R, Math MV, Yap I The effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia — a double-blind placebocontrolled study.Google Scholar
- 8.Shallcross TM, Rathbone BJ, Heatley RV (1989) Campylobacter pylori and non-ulcer dyspepsia. In: Rathbone BJ, Heatley RV (eds) Campylobacter pylori and gastroduodenal disease. Blackwell, Oxford, pp 155–166.Google Scholar